ClinicalTrials.Veeva

Menu

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

S

Suez Canal University

Status

Completed

Conditions

Venous Malformation

Treatments

Drug: Ethanol-amine Oleate Sclerotherapy Injection

Study type

Observational

Funder types

Other

Identifiers

NCT04930952
157-2018

Details and patient eligibility

About

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Full description

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent.

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations

Enrollment

15 patients

Sex

All

Ages

Under 12 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: maxillofacial venous malformation

Exclusion Criteria:

  1. Patients with lung, liver, or kidney diseases
  2. Patients with Klippel-Trenaunay syndrome
  3. Patients mental or physical disabilities

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems